Open AccessS318 Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP
Author(s) -
Yunus Emre Demirhan,
Praveen Rajendran,
WanMohaiza Dashwood,
Sudhir Kapoor,
Ahmet Uluşan,
Chakrapani Tripathi,
Melek Demirhan,
Alessandro Shapiro,
Michelle I. Savage,
Powel H. Brown,
Shizuko Sei,
Altaf Mohammed,
Eduardo Vilar Sanchez,
WanMohaiza Dashwood
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000773744.48014.a9
Subject(s) - medicine , familial adenomatous polyposis , gastroenterology , sulindac , toxicity , erlotinib , colonoscopy , colorectal cancer , cancer , nonsteroidal , epidermal growth factor receptor